RIME earnings analysis
What we found in RIME's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
The provided filing extract does not include the income statement, balance sheet, cash-flow statement, or segment disclosures, so revenue, margins, EPS, liquidity, and free cash flow cannot be assessed from the available information. The principal adverse signal is that disclosure controls and internal control over financial reporting remained ineffective, with 3 material weaknesses identified. The company also paid $500,000 on July 2, 2026 to settle Blue Yonder litigation, while quantitative guidance was not provided.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Blue Yonder litigation settled
- The company paid $500,000 on July 2, 2026 to settle all claims in the Blue Yonder litigation; Blue Yonder released the company and its subsidiaries and filed a satisfaction of judgment.
- No new control changes reported
- During the fiscal quarter ended June 30, 2026, management reported no additional changes to internal control over financial reporting that materially affected, or were reasonably likely to materially affect, controls.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Material control weaknesses persist
- The CEO and CFO concluded that disclosure controls and procedures were not effective as of June 30, 2026. The filing identifies 3 material weaknesses tied to insufficient accounting resources, segregation of duties, and revenue controls.
- Post-quarter legal cash outflow
- The company paid $500,000 on July 2, 2026 to resolve the Blue Yonder matter, creating a cash outflow after quarter-end despite eliminating the related litigation claims.
- Remediation costs and timing uncertain
- Management stated that it may hire 1 or more accounting personnel to remediate the weaknesses, but the filing does not provide a completion date or quantified remediation cost.
What they said about what is next.
The provided 10-Q extract contains no quantitative revenue or EPS outlook and no explicit forward guidance.
The filing reads worse than the one before it.
What came before.
- 10-Q · May 14, 2026
- RIME reported a significant increase in net sales to $2.4 million in Q4 2026, compared to $123,000 in the same quarter of the previous year, driven by the SemiCab business. Despite this growth, the company reported a…
- 10-K · April 2, 2026
- Algorhythm (RIME) repositioned as an AI logistics company around its SemiCab platform after selling the Singing Machine business on August 1, 2025 for $500,000, completed an acquisition of SMCB for $1,750,000 (with…
- 10-Q · November 19, 2025
- Algorhythm (RIME) reported Q3 net sales of $1,744,000 (vs. $127,000 in Q3 2024), producing a gross loss of $351,000 and a continuing-operations loss per share of $(0.72). The quarter reflects strong top-line expansion…
- 10-K · April 15, 2025
- Algorhythm Holdings (RIME) 10-K describes a two‑pillar strategy: grow its legacy Singing Machine consumer karaoke products while scaling SemiCab, an AI logistics/SaaS business acquired July 3, 2024 (consideration: 3,210…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing RIME makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever